Actually they did have a much better deal... They could have bought SLP. SLP has a nice growth rate, in sales, earnings and stock holder equity as well as zero debt. I'm sure they must be aware of SLP since SMMX just announced a partnership agreement with them. SLP is much smaller but it comes with first class management and a pristine balance sheet, as a result it is also a bit more expensive on a per share valuation. ACCL now has enough money they could easily buy SLP at a much higher valuation that would be warranted. SLP's GastroPlus software is so good that research scientists presenting at professional meetings refer to it as the basis for their findings.